Tilman Oltersdorf

Title: The Innovations of Tilman Oltersdorf

Introduction

Tilman Oltersdorf is a prominent inventor based in Cardiff, California. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid molecules and polypeptides. With a total of seven patents to his name, Oltersdorf's work has had a substantial impact on scientific research and therapeutic applications.

Latest Patents

Oltersdorf's latest patents include groundbreaking inventions related to CRF receptors and human Bad polypeptides. The first patent provides isolated nucleic acid molecules encoding CRF receptors, along with recombinant expression vectors and host cells suitable for expressing these receptors. This invention also encompasses compositions and methods that utilize such receptors. The second patent focuses on an isolated gene and nucleic acid sequence encoding human Bad and its functional fragments. It also includes methods for identifying human Bad binding partners and screening for compounds that interfere with the association of human Bad interacting polypeptides. Additionally, methods for modulating the viability of cells are provided.

Career Highlights

Throughout his career, Tilman Oltersdorf has worked with notable companies such as Neurocrine Biosciences, Inc. and Idun Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate on various innovative projects that advance the field of biotechnology.

Collaborations

Oltersdorf has collaborated with esteemed colleagues, including Timothy W. Lovenberg and Chen Wang Liaw. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Tilman Oltersdorf's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the field and offers promising avenues for future research and therapeutic development.